$HRTX, The Heron Therapeutics Inc (HRTX) Earns Buy

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
537
$HRTX,

The Heron Therapeutics Inc (HRTX) Earns Buy Rating from Analysts at Needham & Company LLC
March 10, 2017 Darlene McCollum
The Heron Therapeutics Inc (HRTX) Earns Buy Rating from Analysts at Needham & Company LLC

Needham & Company LLC started coverage on shares of Heron Therapeutics Inc (NASDAQ:HRTX) in a research note published on Monday. The brokerage issued a buy rating and a $28.00 price target on the biotechnology company’s stock.

A number of other brokerages also recently issued reports on HRTX. JMP Securities reaffirmed a buy rating on shares of Heron Therapeutics in a research report on Wednesday, November 9th. Jefferies Group LLC set a $29.00 target price on shares of Heron Therapeutics and gave the stock a buy rating in a research note on Thursday, January 5th. Cantor Fitzgerald reiterated an overweight rating and issued a $34.00 target price on shares of Heron Therapeutics in a research note on Friday, January 6th. Cowen and Company reiterated a buy rating and issued a $40.00 target price on shares of Heron Therapeutics in a research note on Sunday, December 11th. Finally, Zacks Investment Research cut shares of Heron Therapeutics from a hold rating to a sell rating in a research note on Tuesday, January 10th. One research analyst has rated the stock with a sell rating and ten have given a buy rating to the stock. The company has an average rating of Buy and a consensus price target of $36.22.

Heron Therapeutics (NASDAQ:HRTX) traded down 1.37% during mid-day trading on Monday, hitting $14.40. 596,714 shares of the stock were exchanged. Heron Therapeutics has a 52 week low of $12.21 and a 52 week high of $25.46. The company has a 50-day moving average of $13.50 and a 200-day moving average of $15.91.

Heron Therapeutics (NASDAQ:HRTX) last issued its quarterly earnings data on Thursday, February 23rd. The biotechnology company reported ($1.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.17) by $0.05. On average, equities analysts forecast that Heron Therapeutics will post ($3.49) EPS for the current year.

In other news, Director Kevin C. Tang bought 2,459,016 shares of the business’s stock in a transaction that occurred on Thursday, January 19th. The shares were purchased at an average cost of $12.20 per share, for a total transaction of $29,999,995.20. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 20.31% of the stock is currently owned by corporate insiders.

Hedge funds have recently added to or reduced their stakes in the company. FMR LLC raised its stake in Heron Therapeutics by 0.4% in the fourth quarter. FMR LLC now owns 5,872,839 shares of the biotechnology company’s stock worth $76,934,000 after buying an additional 20,545 shares during the last quarter. Janus Capital Management LLC raised its position in shares of Heron Therapeutics by 13.4% in the fourth quarter. Janus Capital Management LLC now owns 4,575,807 shares of the biotechnology company’s stock valued at $59,947,000 after buying an additional 542,007 shares in the last quarter. Broadfin Capital LLC raised its position in shares of Heron Therapeutics by 23.8% in the fourth quarter. Broadfin Capital LLC now owns 3,899,587 shares of the biotechnology company’s stock valued at $51,085,000 after buying an additional 749,587 shares in the last quarter. Baker BROS. Advisors LP bought a new position in shares of Heron Therapeutics during the third quarter valued at approximately $49,230,000. Finally, Highland Capital Management LP raised its position in shares of Heron Therapeutics by 140.2% in the fourth quarter. Highland Capital Management LP now owns 1,562,817 shares of the biotechnology company’s stock valued at $20,473,000 after buying an additional 912,086 shares in the last quarter.

About Heron Therapeutics

Heron Therapeutics, Inc is a biotechnology company engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Company’s product candidates include SUSTOL, HTX-019 and HTX-011. All of its product candidates utilize science and technology platforms, including its Biochronomer drug delivery technology.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 8

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 11

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 10

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 12

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 24

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 5

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 13

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 10

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Bob Evans' Protein Mac & Cheese: Practical Power Play

Updated Category News Views 18

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Continue Reading

Top 5 Most Recently Viewed Articles

Elevate Your Knowledge on Elevance Health and Legal Matters

Updated Category News Views 164

Understanding the Legal Challenges Facing Elevance Health, Inc. Elevance Health, Inc. (NYSE: ELV) finds itself in the spotlight, facing a class action lawsuit that has significant implications for its shareholders. Legal firms are stepping in to represent investors who may have suffered losses due to the company's recent announcements regarding its Medicaid business. As...

Continue Reading
Revolutionizing Solar: Powur's Innovative Fulfillment Model

Updated Category News Views 256

Introducing Powur's Groundbreaking Fulfillment Model Powur PBC, a leader in the solar energy sector, is paving the way for innovation in solar project management. This new model is designed to enhance the delivery and installation of solar systems, ensuring accuracy and efficiency from the beginning of the project lifecycle. Understanding the COGS+ Model The newly...

Continue Reading
Revolutionizing Battery Technology: ProLogium and CEA Partnership

Updated Category News Views 174

Innovative Collaboration for Solid-State Battery Development ProLogium Technology, a leader in solid-state battery innovation, has recently joined forces with the CEA to unveil an ambitious initiative that focuses on the development of sophisticated solid-state battery modules. This collaboration centers around the concept of a "Design-for-Disassembly" structure that aims...

Continue Reading
Australia Employment Surpasses Expectations Despite Jobless Rate

Updated Category News Views 380

December Employment Numbers in Australia Surpass Projections In a noteworthy turn of events, Australian employment statistics for December have shown a remarkable rise, outstripping forecasts largely due to a considerable increase in part-time positions. While the jobless rate experienced a slight uptick, the overall data reflects a thriving labor market. Statistics...

Continue Reading
Vor Biopharma's Major Investment Targets Autoimmune Market Growth

Updated Category News Views 223

Strategic Moves in the Autoimmune Therapy Market Vor Biopharma Inc. (NASDAQ: VOR) is attracting attention with its recent strategic maneuver aimed at revitalizing the company and capitalizing on opportunities in the autoimmune market. The company has announced a notable licensing agreement that signifies its commitment to developing groundbreaking therapies. Licensing...

Continue Reading